Nai-jen Hou

Kaohsiung, KHQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Association Between ADH1B rs1229984 Genetic Polymorphism and Hepatic Steatosis Assessed by CT Attenuation: A Mediation Analysis of Central Obesity in MASLD.

Association Between ADH1B rs1229984 Genetic Polymorphism and Hepatic Steatosis Assessed by CT Attenuation: A Mediation Analysis of Central Obesity in MASLD.

Journal: Journal of gastroenterology and hepatology

Published: February 06, 2026

Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver-Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral Therapy.

Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver-Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral Therapy.

Journal: The Kaohsiung journal of medical sciences

Published: January 13, 2026

Artificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinoma.

Artificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinoma.

Journal: American journal of cancer research

Published: August 23, 2022

Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C cirrhotic patients without overt diabetes.

Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C cirrhotic patients without overt diabetes.

Journal: The Kaohsiung journal of medical sciences

Published: December 26, 2021

Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels.

Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels.

Journal: Cancer medicine

Published: September 14, 2021

Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in nonalcoholic steatohepatitis patients.

Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in nonalcoholic steatohepatitis patients.

Journal: The Kaohsiung journal of medical sciences

Published: July 23, 2021

First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients.

First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients.

Journal: Hepatology international

Published: June 05, 2021

Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals.

Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals.

Journal: PloS one

Published: July 28, 2020

Cure or curd: Modification of lipid profiles and cardio-cerebrovascular events after hepatitis C virus eradication.

Cure or curd: Modification of lipid profiles and cardio-cerebrovascular events after hepatitis C virus eradication.

Journal: The Kaohsiung journal of medical sciences

Published: April 17, 2020

Improvement of hyperuricemia in chronic hepatitis C patients receiving directly acting antiviral agents.

Improvement of hyperuricemia in chronic hepatitis C patients receiving directly acting antiviral agents.

Journal: Journal of gastroenterology and hepatology

Published: April 29, 2019

Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and database.

Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and database.

Journal: Medicine

Published: June 01, 2017

Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohort.

Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohort.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: December 13, 2016

Showing 1-12 of 21

Last Updated: 09/26/2026